p300-Dependent ATF5 Acetylation Is Essential for Egr-1 Gene Activation and Cell Proliferation and Survival

REFERENCES

• Abdulkadir, S. A., et al. 2001. Impaired prostate tumorigenesis in Egr1-deficient mice. Nat. Med. 7: 101–107.
   PubMed Web of Science ®Google Scholar
• Angelastro, J. M., et al. 2006. Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5. Oncogene 25: 907–916.
   PubMedGoogle Scholar
• Angelastro, J. M., et al. 2003. Regulated expression of ATF5 is required for the progression of neural progenitor cells to neurons. J. Neurosci. 23: 4590–4600.
   PubMed Web of Science ®Google Scholar
• Angelastro, J. M., et al. 2005. Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytes. J. Neurosci. 25: 3889–3899.
   PubMedGoogle Scholar
• Balasubramanyam, K., et al. 2004. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J. Biol. Chem. 279: 33716–33726.
   PubMed Web of Science ®Google Scholar
• Bannister, A. J., E. A. Miska, D. Gorlich, and T. Kouzarides. 2000. Acetylation of importin-alpha nuclear import factors by CBP/p300. Curr. Biol. 10: 467–470.
   PubMed Web of Science ®Google Scholar
• Barlev, N. A., et al. 2001. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8: 1243–1254.
   PubMed Web of Science ®Google Scholar
• Baron, V., et al. 2003. Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo. Oncogene 22: 4194–4204.
   PubMed Web of Science ®Google Scholar
• Chan, H. M., and N. B. La Thangue. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114: 2363–2373.
   PubMed Web of Science ®Google Scholar
• Cheung, P., et al. 2000. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5: 905–915.
   PubMed Web of Science ®Google Scholar
• Clarkson, R. W., C. A. Shang, L. K. Levitt, T. Howard, and M. J. Waters. 1999. Ternary complex factors Elk-1 and Sap-1a mediate growth hormone-induced transcription of egr-1 (early growth response factor-1) in 3T3-F442A preadipocytes. Mol. Endocrinol. 13: 619–631.
   PubMedGoogle Scholar
• Dluzen, D., G. Li, D. Tacelosky, M. Moreau, and D. X. Liu. 2011. Bcl-2 is a downstream target of ATF5 that mediates ATF5's pro-survival function. J. Biol. Chem. 286: 7705–7713.
   PubMedGoogle Scholar
• Dornan, D., H. Shimizu, L. Burch, A. J. Smith, and T. R. Hupp. 2003. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53. Mol. Cell. Biol. 23: 8846–8861.
   PubMedGoogle Scholar
• Eid, M. A., M. V. Kumar, K. A. Iczkowski, D. G. Bostwick, and D. J. Tindall. 1998. Expression of early growth response genes in human prostate cancer. Cancer Res. 58: 2461–2468.
   PubMedGoogle Scholar
• Franken, N. A., H. M. Rodermond, J. Stap, J. Haveman, and C. van Bree. 2006. Clonogenic assay of cells in vitro. Nat. Protoc. 1: 2315–2319.
   PubMed Web of Science ®Google Scholar
• Giordano, A., and M. L. Avantaggiati. 1999. p300 and CBP: partners for life and death. J. Cell. Physiol. 181: 218–230.
   PubMed Web of Science ®Google Scholar
• Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14: 1553–1577.
   PubMed Web of Science ®Google Scholar
• Greene, L. A., H. Y. Lee, and J. M. Angelastro. 2009. The transcription factor ATF5: role in neurodevelopment and neural tumors. J. Neurochem. 108: 11–22.
   PubMedGoogle Scholar
• Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595–606.
   PubMed Web of Science ®Google Scholar
• Hai, T. W., F. Liu, W. J. Coukos, and M. R. Green. 1989. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3: 2083–2090.
   PubMed Web of Science ®Google Scholar
• Han, W., and G. N. Liu. 2010. EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat. Life Sci. 86: 234–243.
   PubMedGoogle Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100: 57–70.
   PubMed Web of Science ®Google Scholar
• Hipskind, R. A., D. Buscher, A. Nordheim, and M. Baccarini. 1994. Ras/MAP kinase-dependent and -independent signaling pathways target distinct ternary complex factors. Genes Dev. 8: 1803–1816.
   PubMed Web of Science ®Google Scholar
• Kabotyanski, E. B., et al. 2009. Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J. Biol. Chem. 284: 22815–22824.
   PubMedGoogle Scholar
• Khachigian, L. M., V. Lindner, A. J. Williams, and T. Collins. 1996. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271: 1427–1431.
   PubMedGoogle Scholar
• Kouzarides, T. 2007. Chromatin modifications and their function. Cell 128: 693–705.
   PubMed Web of Science ®Google Scholar
• Lassot, I., et al. 2005. p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain. J. Biol. Chem. 280: 41537–41545.
   PubMedGoogle Scholar
• Levy, L., et al. 2004. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol. Cell. Biol. 24: 3404–3414.
   PubMedGoogle Scholar
• Li, G., W. Li, J. M. Angelastro, L. A. Greene, and D. X. Liu. 2009. Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells. Mol. Cancer Res. 7: 933–943.
   PubMedGoogle Scholar
• Li, G., Y. Xu, D. Guan, Z. Liu, and D. X. Liu. 2011. HSP70 promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation. J. Biol. Chem. 286: 20251–20259.
   PubMedGoogle Scholar
• Li, G., et al. 2010. Highly compacted chromatin formed in vitro reflects the dynamics of transcription activation in vivo. Mol. Cell 38: 41–53.
   PubMed Web of Science ®Google Scholar
• Liao, J., et al. 1997. Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element. J. Biol. Chem. 272: 25951–25958.
   PubMedGoogle Scholar
• Liu, D. X., N. Nath, S. P. Chellappan, and L. A. Greene. 2005. Regulation of neuron survival and death by p130 and associated chromatin modifiers. Genes Dev. 19: 719–732.
   PubMed Web of Science ®Google Scholar
• Ma, J., et al. 2009. Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy. J. Biol. Chem. 284: 34600–34606.
   PubMedGoogle Scholar
• Macdonald, N., et al. 2005. Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol. Cell 20: 199–211.
   PubMed Web of Science ®Google Scholar
• Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381–393.
   PubMed Web of Science ®Google Scholar
• Mason, J. L., et al. 2005. ATF5 regulates the proliferation and differentiation of oligodendrocytes. Mol. Cell Neurosci. 29: 372–380.
   PubMed Web of Science ®Google Scholar
• McManus, K. J., and M. J. Hendzel. 2003. Quantitative analysis of CBP- and P300-induced histone acetylations in vivo using native chromatin. Mol. Cell. Biol. 23: 7611–7627.
   PubMedGoogle Scholar
• Monaco, S. E., J. M. Angelastro, M. Szabolcs, and L. A. Greene. 2007. The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines. Int. J. Cancer 120: 1883–1890.
   PubMed Web of Science ®Google Scholar
• Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953–959.
   PubMed Web of Science ®Google Scholar
• Parra, E., and J. Ferreira. 2010. The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines. Oncol. Rep. 23: 1159–1165.
   PubMedGoogle Scholar
• Persengiev, S. P., L. R. Devireddy, and M. R. Green. 2002. Inhibition of apoptosis by ATFx: a novel role for a member of the ATF/CREB family of mammalian bZIP transcription factors. Genes Dev. 16: 1806–1814.
   PubMedGoogle Scholar
• Price, M. A., A. E. Rogers, and R. Treisman. 1995. Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). EMBO J. 14: 2589–2601.
   PubMed Web of Science ®Google Scholar
• Saint Just Ribeiro, M., M. L. Hansson, and A. E. Wallberg. 2007. A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1. Biochem. J. 404: 289–298.
   PubMedGoogle Scholar
• Sheng, Z., et al. 2010. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat. Med. 16: 671–677.
   PubMedGoogle Scholar
• Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64: 435–459.
   PubMed Web of Science ®Google Scholar
• Sukhatme, V. P., et al. 1988. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53: 37–43.
   PubMed Web of Science ®Google Scholar
• Sun, Y., X. Jiang, S. Chen, and B. D. Price. 2006. Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett. 580: 4353–4356.
   PubMed Web of Science ®Google Scholar
• Svaren, J., et al. 2000. EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J. Biol. Chem. 275: 38524–38531.
   PubMedGoogle Scholar
• Tanaka, Y., et al. 2000. Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech. Dev. 95: 133–145.
   PubMed Web of Science ®Google Scholar
• Tang, Y., W. Zhao, Y. Chen, Y. Zhao, and W. Gu. 2008. Acetylation is indispensable for p53 activation. Cell 133: 612–626.
   PubMed Web of Science ®Google Scholar
• Tolhuis, B., R. J. Palstra, E. Splinter, F. Grosveld, and W. de Laat. 2002. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell 10: 1453–1465.
   PubMed Web of Science ®Google Scholar
• Vo, N., and R. H. Goodman. 2001. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276: 13505–13508.
   PubMed Web of Science ®Google Scholar
• Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403–407.
   PubMed Web of Science ®Google Scholar
• Yao, T. P., et al. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93: 361–372.
   PubMed Web of Science ®Google Scholar
• Yu, J., I. de Belle, H. Liang, and E. D. Adamson. 2004. Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol. Cell 15: 83–94.
   PubMedGoogle Scholar